| |
|
 |
|
| |
:: Press Release
|
France Biotech
|
BDC is pleased to announce its membership to FRANCE BIOTECH.
France Biotech is the French
biotechnology association and the industry representative. Its mission
is to contribute to position France and Europe as leaders in the Life
sciences industry.
France Biotech is acting on the four key factors of success for a strong biotechnology industry:
- Improving the academic R&D dynamics and funding: France Biotech
supported the Strategic Council for Innovation (SCI) when it made a
series of proposals including the creation of a National Science
Agency, project accepted by the French government on June 2004, and the
focusing of the Agency’s budget on Life Sciences and Nanobiosciences
- Ensuring a liquid chain of financing for young biotechnology companies
(from seed funding to the stock market): France Biotech has designed
and proposed, with the SCI, the status of Young Innovative Enterprise
(Jeune Entreprise Innovante, JEI, in french). The government
implemented this law proposal on January 1st 2004, which now makes
France the most attractive country for young research-driven companies
and subsidiaries from a tax and social costs standpoint. More recently,
France Biotech and a few other organisations of entrepreneurs and
investors triggered an initiative that led to the commitment made by
the Life insurance companies to invest an additional 6 billion euros in
private equity. France Biotech is now proposing the government to
provide fiscal incentives for investors that will invest in Young
Listed Enterprises (Jeune Entreprise Cotée, JEC, in french), in order
to prevent the lack of appetite encountered by young technology
companies on the European stock markets.
- Working on the
manageurial environment within its through members networking,
benchmarking activities, good practices sharing, etc.
- Improving public perception and understanding of life science: in 2004,
the association organized BioPicture (the first ever international
biotech film and image festival), with the goal of communicating a
positive image of life science to the general public; and, in
partnership with Europabio (the European Association of Bioindustrie),
Leem (the French pharmaceutical association), LIR (International
Research Laboratories association) and BIA, France Biotech created
www.bioimpact.org; web site of reference on the benefits of innovative
biotechnology-derived medicines for patients.
France Biotech gathers 150 members, representing the majority of the French biotechnology investments, pipeline and employees.Come meet us at the European Venture Summit 2006 in Lisbon, Portugal, the 4 & 5 December.
Over 150 innovative growth companies across all technology sectors
seeking international finance or partners have the opportunity to
present their business projects to Europe’s most active investors and
corporate partners. Pre-arranged One2One® meetings will be organized
between corporate and venture investors and the presenting
entrepreneurs.
The Summit will bring together the tested success of our previous events:
|
|
File Type
|
Description
|
Date
|
Filename
|
|
|
|
|
|
|
|
